BioWorld

July 16, 2003

View Archived Issues

MIT Scientist Rejects Mutagenic Cause of Neoplasms; Espouses Outside Factors Over Mutations

Read More

Industry Reps Continue Debating The Issue Of Generic Biologics

Read More

Several Hybridon Presentations Highlight Early Cancer Platform

Read More

Other News To Note

Read More

Trimeris, Roche Increase Capacity For Fuzeon, Release More Data

Reports of increased global supplies of Fuzeon, coupled with longer-term data on the product, gave Trimeris Inc. a boost from investors eyeing higher earnings from early sales of the FDA-approved HIV drug. (BioWorld Today) Read More

Medivir, Boehringer Ingelheim Enter Potential EUR122M Alliance

Read More